Horisberger A - Search Results

1

Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE.

Humbel M, Bellanger F, Fluder N, Horisberger A, Suffiotti M, Fenwick C, Ribi C, Comte D. Humbel M, et al. Among authors: horisberger a. Front Immunol. 2021 Mar 22;12:645478. doi: 10.3389/fimmu.2021.645478. eCollection 2021. Front Immunol. 2021. PMID: 33828555 Free PMC article. Clinical Trial.

2

SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus.

Humbel M, Bellanger F, Horisberger A, Suffiotti M, Fluder N, Makhmutova M, Mathias A, Du Pasquier R, Fenwick C, Ribi C, Comte D. Humbel M, et al. Among authors: horisberger a. Front Immunol. 2022 May 6;13:843059. doi: 10.3389/fimmu.2022.843059. eCollection 2022. Front Immunol. 2022. PMID: 35603218 Free PMC article.

3

Measurement of circulating CD21^-CD27^- B lymphocytes in SLE patients is associated with disease activity independently of conventional serological biomarkers.

Horisberger A, Humbel M, Fluder N, Bellanger F, Fenwick C, Ribi C, Comte D. Horisberger A, et al. Sci Rep. 2022 Jun 2;12(1):9189. doi: 10.1038/s41598-022-12775-4. Sci Rep. 2022. PMID: 35654865 Free PMC article.

4

The Fatigue Assessment Scale as a simple and reliable tool in systemic lupus erythematosus: a cross-sectional study.

Horisberger A, Courvoisier D, Ribi C. Horisberger A, et al. Arthritis Res Ther. 2019 Mar 25;21(1):80. doi: 10.1186/s13075-019-1864-4. Arthritis Res Ther. 2019. PMID: 30909957 Free PMC article.

5

Impact of COVID-19 pandemic on SLE: beyond the risk of infection.

Horisberger A, Moi L, Ribi C, Comte D. Horisberger A, et al. Lupus Sci Med. 2020 May;7(1):e000408. doi: 10.1136/lupus-2020-000408. Lupus Sci Med. 2020. PMID: 32376774 Free PMC article. No abstract available.

6

[Biologics and systemic lupus erythematosous : new insights and perspectives].

Clottu A, Horisberger A, Comte D. Clottu A, et al. Among authors: horisberger a. Rev Med Suisse. 2021 Apr 7;17(733):684-689. Rev Med Suisse. 2021. PMID: 33830700 French.

7

[Autoimmune diseases in the context of pandemic COVID-19].

Horisberger A, Moi L, Ribi C, Comte D. Horisberger A, et al. Rev Med Suisse. 2020 Apr 29;16(N° 691-2):827-830. Rev Med Suisse. 2020. PMID: 32348045 Review. French.

8

[Management of the antiphospholipid syndrome in adults].

Doms J, Horisberger A, Ribi C. Doms J, et al. Among authors: horisberger a. Rev Med Suisse. 2020 Apr 8;16(689):670-674. Rev Med Suisse. 2020. PMID: 32270932 Review. French.

9

[Risk of treatment failure and therapeutic novelties in asthma].

Horisberger A, Mahdi Aljedani R, Spertini F, Ribi C. Horisberger A, et al. Rev Med Suisse. 2019 Jan 9;15(N° 632-633):23-26. Rev Med Suisse. 2019. PMID: 30629362 French.

10

ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis.

Horisberger A, Pantazou V, Cuendet G, Ribi C, Dunet V, Théaudin M. Horisberger A, et al. Mult Scler. 2020 Oct;26(12):1599-1602. doi: 10.1177/1352458519895449. Epub 2020 Feb 21. Mult Scler. 2020. PMID: 32081100

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters